Independent report · Private Markets

Reliance Consumer Products and Manna: Southern Health Foods (Manna)

· By Reena

I.S.A.K. Nazar, founder and managing director of Southern Health Foods, the maker of the Manna brand, in his office with Manna products on the shelf. · Image: The Weekend Leader (photo: H K Rajashekar)

I.S.A.K. Nazar, founder and managing director of Southern Health Foods, the maker of the Manna brand, in his office with Manna products on the shelf. · Image: The Weekend Leader (photo: H K Rajashekar)

Independent report content

BUYERReliance Consumer Products Ltd (RCPL), the FMCG arm of Reliance Industries; a direct RIL subsidiary since 1 December 2025
TARGETSouthern Health Foods Pvt Ltd, Tamil Nadu, owner of the Manna health-food brand · founder I.S.A.K. Nazar
PRICE AND STAKE₹156.42 Cr in cash for 100% · one outlet headline says ₹156 Cr, one report says about ₹158 Cr, DT Next says undisclosed
DATESAnnounced 10 Feb 2026 · effective 9 Feb 2026 · the brief's April 2026 date is not supported by any source found
SELLERS AND ADVISERSNHPEA Summer Holding B.V. (Morgan Stanley) and Fulcrum, an exit for all existing shareholders · Khaitan & Co. for the buyer, Shardul Amarchand Mangaldas and IC RegFin Legal for the sellers
TARGET TURNOVERFY23 ₹126.65 Cr · FY24 ₹127.37 Cr · FY25 ₹109.40 Cr (down about 14.1%) · profit not reported
PRICE TO REVENUE₹156.42 Cr ÷ ₹109.40 Cr = 1.43x on FY25 turnover (Rupeia arithmetic, not a published multiple)
PAHADI LOCALReliance Retail Ltd completed the acquisition of the beauty and wellness brand and business on 9 Mar 2026 from Pahadi Goodness Pvt Ltd · price not disclosed
THE ACCESS POINT Manna is now wholly owned by RCPL and cannot be bought separately. The only listed route is Reliance Industries shares on NSE and BSE, where this deal is one small part of a much larger group.

Executive decision summary

THE BOTTOM LINEReliance's FMCG arm has bought a Tamil Nadu health-food brand outright, and the brief had the wrong month. RCPL acquired 100% of Southern Health Foods, owner of Manna, for ₹156.42 crore in cash. The deal took effect on 9 February 2026 and was announced on 10 February, not in April. The sellers were NHPEA Summer Holding (Morgan Stanley) and Fulcrum, and all existing shareholders exited. Southern Health Foods' turnover was ₹126.65 crore in FY23, ₹127.37 crore in FY24 and ₹109.40 crore in FY25, a fall of about 14.1%; profit was not reported. The price is therefore about 1.43 times FY25 turnover. Separately, Reliance Retail completed the purchase of the Pahadi Local beauty brand on 9 March 2026 and did not disclose the price.
WHICH INVESTORThe Manna deal fits a corporate-development or consumer-sector reader IF you want a worked example of how Reliance is buying regional brands one at a time. Wait IF you need the target's profit, a published valuation multiple or the use of the money: none was found.
COMFORT FITFMCG = fast-moving consumer goods, everyday products such as packaged food and personal care. Turnover = the target's sales, before costs. Millets = small-grain cereals such as ragi and jowar, used in health foods. Wholly owned subsidiary = a company in which the buyer holds all the shares.
THE RUPEIA NUMBER14.1%. The fall in Southern Health Foods' turnover in FY25, from ₹127.37 Cr to ₹109.40 Cr, the year before RCPL paid ₹156.42 Cr.

1 CLAIM REGISTER: EVIDENCE GRADING

ClaimSourceGradeRupeia assessment
RCPL bought 100% of Southern Health Foods for ₹156.42 Cr cashBusinessToday; Bar & BenchBEstablished
Deal dated April 2026 (the brief)None foundDCorrected: effective 9 Feb 2026, announced 10 Feb 2026
Price: ₹156 Cr (headline), about ₹158 Cr (one report), "undisclosed" (DT Next)BusinessToday; search summaries; DT NextDConflict; ₹156.42 Cr is the filing-based figure
Sellers NHPEA Summer Holding (Morgan Stanley) and FulcrumBar & BenchCSingle detailed source
Turnover ₹126.65 Cr, ₹127.37 Cr, ₹109.40 Cr in FY23–FY25BusinessToday citing the filingBEstablished; profit not reported
Manna "growing at over 40% annually"Search summary, undatedDConflicts with the filing trend
N. Murugan is CEO of Southern Health FoodsSearch summary; page not openedDNot confirmed
Reliance Retail completed Pahadi Local on 9 Mar 2026; price not disclosedRIL press release; InvestywiseACompany statement; no financials

2 THE MANNA DEAL: TERMS, SELLERS AND ADVISERS

The Manna range of health-food products. · Image: DT Next
The Manna range of health-food products. · Image: DT Next
ItemDetail
BuyerReliance Consumer Products Ltd, which became a direct Reliance Industries subsidiary on 1 December 2025 (BusinessToday; DT Next)
TargetSouthern Health Foods Pvt Ltd, owner of the Manna brand; now a wholly owned RCPL subsidiary
Price₹156.42 Cr, all cash, for 100% of the equity
DatesEffective 9 Feb 2026; announced 10 Feb 2026 (BusinessToday); Bar & Bench published its advisers article on 12 Mar 2026
SellersNHPEA Summer Holding B.V. (Morgan Stanley) and Fulcrum; "exit for all existing shareholders" (Bar & Bench)
AdvisersBuyer: Khaitan & Co. NHPEA: Shardul Amarchand Mangaldas (Nivedita Tiwari, Partner). Fulcrum: IC RegFin Legal (Puneet Shah, Partner)
Use of the moneyNot disclosed
Valuation multiplesNot stated in any source opened: no EV to revenue or EV to EBITDA
Calculation (Rupeia)Result
Gap between the two price figures₹158 Cr − ₹156.42 Cr = ₹1.58 Cr
That gap as a share of the price₹1.58 Cr ÷ ₹156.42 Cr = 1.0%
Price in US dollars at ₹96.5₹1,564.2 million ÷ 96.5 = US$16.2m
RUPEIA READ The terms are simple: a full cash buyout with every existing shareholder leaving. The price differences between outlets are small, about 1%, and the filing-based ₹156.42 crore is the figure used here. The brief's April date does not appear in any source; the deal took effect in February. What the sources do not give is the use of the money or any valuation multiple.

3 SOUTHERN HEALTH FOODS: TURNOVER AND PEOPLE

YearTurnover (₹ Cr)ChangeSource
FY23126.65Base yearBusinessToday citing the filing
FY24127.37Up about 0.6%BusinessToday
FY25109.40Down about 14.1%BusinessToday
201648 (older figure)Weekend Leader profile, date not confirmedThe Weekend Leader
PersonRole and detailSource
I.S.A.K. NazarFounder of Southern Health Foods; a former medical representative from Tirunelveli, later marketing head for Tamil Nadu at Helios Pharmaceuticals, MaduraiThe Weekend Leader (2016 profile)
T KrishnakumarDirector, RCPL; called Manna "one of the most trusted names in the health focused foods market in Tamil Nadu"BusinessToday
N. MuruganCEO of Southern Health Foods per a search summary; page not openedNot confirmed
Calculation (Rupeia)Result
FY24 against FY23₹127.37 Cr − ₹126.65 Cr = ₹0.72 Cr, or ₹0.72 Cr ÷ ₹126.65 Cr = 0.6%
FY25 fall in rupees₹127.37 Cr − ₹109.40 Cr = ₹17.97 Cr
FY25 fall as a share of FY24₹17.97 Cr ÷ ₹127.37 Cr = 14.1%
FY25 against FY23₹109.40 Cr ÷ ₹126.65 Cr − 1 = −13.6%
FY25 turnover against the 2016 figure₹109.40 Cr ÷ ₹48 Cr = 2.28x over about nine years, an average near 10% a year
The "40% a year" claim over the same periodGrowth of 40% a year for nine years would be 1.4 to the power 9, about 20.7x, against the 2.28x shown
RUPEIA READ Turnover was flat for two years and then fell about a seventh in FY25, with no reason given. The undated claim of growth above 40% a year cannot be reconciled with either the filing figures or the 2016 starting point, so it carries little weight. Profit, EBITDA and margins are not reported, which means the quality of the business RCPL bought cannot be judged from the sources.

4 WHAT RCPL PAID: PRICE AGAINST TURNOVER

BasisTurnover (₹ Cr)Price multiple
FY25 (latest)109.401.43x
FY24 (peak)127.371.23x
FY25 if the fall repeated in FY26 (illustration)93.971.66x
Calculation (Rupeia)Result
Price to FY25 turnover₹156.42 Cr ÷ ₹109.40 Cr = 1.43x
Price to FY24 turnover₹156.42 Cr ÷ ₹127.37 Cr = 1.23x
FY26 turnover if turnover fell another 14.1%₹109.40 Cr × 0.859 = ₹93.97 Cr
Price to that illustrative turnover₹156.42 Cr ÷ ₹93.97 Cr = 1.66x
RCPL's quarter annualised₹5,065 Cr × 4 = ₹20,260 Cr, so the target's ₹109.40 Cr is 0.5% of a year
RUPEIA READ On turnover alone the price is modest at 1.43 times, and RCPL is a much larger business: Southern Health Foods is about half of one percent of an annualised year of RCPL revenue. A multiple of sales says little without profit, and profit was not reported. RCPL's stated goal is revenue of ₹1 trillion within five years, which is a company goal and not a forecast; Manna is a small step towards that figure.

5 RCPL'S ACQUISITION RECORD

YearBrand or targetDealSource
Aug 2022Campa ColaAbout ₹22 CrStoryboard18
May 2023Lotus Chocolate51% for ₹74 Cr, plus ₹25 Cr of non-cumulative redeemable preference shares; open offer completed; control from 24 May 2023IIFL
2024Ravalgaon (Pan Pasand, Mango Mood)₹27 Cr for brand assets (trademarks, recipes, IP), not the whole company5paisa; Venture Intelligence
UndatedVelvette (shampoo, Tamil Nadu)Undisclosed; date not confirmed in search resultsOutlook Business (snippet)
Feb 2026Southern Health Foods (Manna)₹156.42 Cr, 100%BusinessToday
Mar 2026Pahadi Local (Reliance Retail)UndisclosedRIL press release
Calculation (Rupeia)Result
Lotus Chocolate stake plus preference shares₹74 Cr + ₹25 Cr = ₹99 Cr
Lotus implied value for 100%₹74 Cr ÷ 0.51 = ₹145.1 Cr (equity price only)
Four deals with a disclosed price₹22 Cr + ₹74 Cr = ₹96 Cr; ₹96 Cr + ₹27 Cr = ₹123 Cr; ₹123 Cr + ₹156.42 Cr = ₹279.42 Cr
Manna as a share of those four₹156.42 Cr ÷ ₹279.42 Cr = 56.0%
Manna against the next largest, Lotus equity₹156.42 Cr ÷ ₹74 Cr = 2.1x
RUPEIA READ Every earlier RCPL purchase was smaller, and two of the five were asset or minority-style deals rather than full buyouts. Manna is the largest priced deal in the record and the first full buyout of a regional food brand, accounting for 56% of the priced total. The Velvette deal, including a reported licence of CNE brands, comes from a search snippet and is not confirmed.

6 PAHADI LOCAL: THE SECOND DEAL

ItemDetailSource
BuyerReliance Retail Ltd (not RCPL)RIL press release
SellerPahadi Goodness Pvt LtdRIL press release; Investywise
Completed9 March 2026RIL press release via NSE filing
BusinessBeauty and wellness brand and businessInvestywise
Price, revenue, financialsNot disclosedn/a
FoundersNot named in the sources; the founding team stays on for creative directionRIL press release
Reliance voiceIsha Ambani, Executive Director, Reliance Retail Ventures Ltd, quoted in paraphraseInvestywise
RUPEIA READ Pahadi Local sits under Reliance Retail and not RCPL, so the two February and March deals are not one programme in the sources. With no price, revenue or founder names published, no calculation is possible beyond the 28 days that separate the two completions. The sources do not say whether the deals are linked.

7 MARKET CONTEXT: MILLETS AND HEALTH FOODS

Market measureFigureSource
India millets market, 2025US$520 million, or US$98.02 million with 5.09% CAGR for 2026–2034Two sources; Deep Market Insights for the lower figure
Packaged millet foodsUS$39.5 million (2022) to US$78.5 million (2029); another report US$91.1 million by 2032 at 9.2% CAGRReport cited in sources; TMR via Tata
Health and wellness foodAbout US$105.0 billion (2024) to US$173.0 billion by 2035, about 4.6% CAGRWhalesbook, no source named
Manna millet mixAim to raise millet products from 60% to 80% of the portfolioSearch summary; page not opened
RCPL food peersUdhaiyam, Independence, SiLBusinessToday; RIL statement
Calculation (Rupeia)Result
Spread between the two India estimatesUS$520m ÷ US$98.02m = 5.3x for the same year
Manna turnover in US dollars at ₹96.5₹1,094 million ÷ 96.5 = US$11.3m
Against the lower market estimateUS$11.3m ÷ US$98.02m = 11.6%
Against the higher market estimateUS$11.3m ÷ US$520m = 2.2%
Millet mix target80% ÷ 60% = 1.33x, a rise of 20 percentage points
RUPEIA READ The millet market estimates differ by a factor of more than five for the same year, so they show direction and not size. Manna's share of the market could be anything from about 2% to about 12% depending on which estimate is taken, and the sources do not say which definition fits Manna's products. The shift towards millets is a management aim recorded in one summary and not a confirmed plan.

8 RISKS, SCENARIOS AND CHECKLIST

RiskEvidenceSeverityKill condition
Turnover declineFY25 turnover down 14.1% with no reason givenHIGHDecline continues after the deal
Profit not disclosedNo EBITDA, PAT or margins foundHIGHTarget proves loss-making
Price conflict₹156.42 Cr, about ₹158 Cr or undisclosedLOWA filing shows a different figure
Date conflictApril 2026 (brief) against 9–10 Feb 2026LOWCorrected here to February
Growth claim"Over 40% a year" is undated and conflicts with filingsMEDIUMClaim reused in marketing
Market sizeMillet estimates differ by 5.3xMEDIUMShare of market misjudged
Pahadi LocalNo price, revenue or financialsMEDIUMImpact on Reliance Retail not measurable
ScenarioWhat happensOutcome
BullTurnover returns to the FY24 level of ₹127.37 Cr under Reliance distributionPrice becomes 1.23x turnover
BaseTurnover stays at ₹109.40 CrPrice stays at 1.43x turnover
BearTurnover falls another 14.1% to about ₹93.97 CrPrice becomes 1.66x turnover
Investor classFitWhy
Listed-market investorLIMITEDManna is small beside RCPL's ₹5,065 Cr quarterly revenue and cannot be bought alone
Corporate-development readerFITClear record of RCPL buying regional brands
Consumer-sector researcherPARTIALUseful turnover trend but no profit data

Rupeia does not recommend buying or selling any security and is not a SEBI-registered investment adviser or research analyst. Open items are the target's profit, the use of the money, the Pahadi Local price and the reason for the FY25 turnover fall.

9 KEY TERMS USED IN THIS REPORT

The terms below are used in this report. Each is explained in plain words.

TermMeaning
RCPLReliance Consumer Products Ltd, the FMCG arm of Reliance Industries.
FMCGFast-moving consumer goods: everyday packaged products.
TurnoverSales before costs are deducted.
Price to revenueThe price paid divided by the target's annual sales.
MilletsSmall-grain cereals such as ragi, used in health foods.
Wholly owned subsidiaryA company in which the parent holds 100% of the shares.

Frequently asked questions

What did Reliance buy in February 2026?

Reliance Consumer Products bought 100% of Southern Health Foods, owner of the Manna brand, for ₹156.42 crore in cash. It took effect on 9 February and was announced on 10 February 2026.

Was the Manna deal in April 2026?

No source found gives April. BusinessToday dates it February 2026, and Bar & Bench's adviser article is dated 12 March 2026.

Who sold Southern Health Foods?

NHPEA Summer Holding B.V. (Morgan Stanley) and Fulcrum, which Bar & Bench describes as an exit for all existing shareholders.

How big is Southern Health Foods?

Turnover was ₹126.65 crore in FY23, ₹127.37 crore in FY24 and ₹109.40 crore in FY25. Profit was not reported.

What did Reliance pay relative to sales?

About 1.43 times FY25 turnover, from ₹156.42 crore divided by ₹109.40 crore. This is Rupeia arithmetic and not a published multiple.

What is Pahadi Local?

A beauty and wellness brand. Reliance Retail completed its acquisition on 9 March 2026 from Pahadi Goodness Pvt Ltd; the price was not disclosed.

Source log

BusinessToday: RIL's FMCG arm acquires Tamil Nadu-based Southern Health Foods for Rs 156 crore

Bar & Bench: Khaitan, SAM, RegFin act on Reliance's ₹156 crore acquisition of Manna Foods

DT Next: TN's Manna latest to join Reliance's foods list; Southern Health in kitty

Whalesbook: Reliance Consumer Buys Manna Foods for Health Market Dominance

Investywise: Reliance Industries subsidiary acquires Pahadi Local beauty and wellness brand

RIL press release: Reliance Retail Limited acquires PahadiLocal brand along with business

IIFL: Reliance completes acquisition of Lotus Chocolate

The Weekend Leader: ISAK Nazar, founder, Manna, Southern Health Foods

Ken Research: India Millets Market Size, Share & Forecast 2026–2032

Storyboard18: Reliance acquires Ravalgaon's confectionery business with brands Pan Pasand, Mango Mood

DISCLAIMER This document is published strictly for informational, educational and academic record-keeping purposes. The publisher is not a SEBI Registered Investment Adviser (RIA) or Research Analyst (RA). It does not constitute personal investment advice, a financial recommendation, or an offer or solicitation to buy, sell or subscribe to any securities. Investments in the securities market are subject to market risks. Read all related documents carefully before investing.